← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$100K

Shares

16,667

Price

$6

Filed

Apr 3

Insider

Name

Hecht Beth

Title

See Remarks

CIK

0001652410

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,209,840

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.890 to $6.085, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001652410-26-000008

Form Type

4

Issuer CIK

0001867096

Hecht Beth's History

Date Ticker Type Value
2026-04-01 XERS $100K
2026-01-02 XERS $124K
2025-12-01 XERS $117K
2025-11-11 XERS $123K

Other Insiders at XERS (90d)

Insider Bought Sold Last
Brady James Aloysius $60K 2026-03-30